1

Christelle Fasano, PharmD

Montreal InternationalDirector, Business Development

Life Sciences & Health Technologies

Foreign Investments

2018

Quebec’s top priority

in Life Sciences

BIO-

MANUFACTURING

2

LIFE SCIENCES & HEALTH TECH: A KEY SECTOR FOR QUEBEC’SECONOMY

19

Province of Quebec

56,000 jobs(80% concentrated in Montreal)

+650 companies

LIFE SCIENCES AND HEALTH TECHNOLOGIES

++++

0 10 000 20 000 30 000 40 000 50 000 60 000

Visual effects

Gaming

Clean tech

Aluminium

Aerospace

Life Sciences & Health Tech

Number of jobs by cluster, Quebec, 2018

3

SNAPSHOT OF FOREIGN COMPANIESTHAT HAVE CHOSEN MONTREAL FOR THEIR CANADIAN FOOTPRINT

4

A SECTOR SUPPORTED BY A NEW STRATEGY (2017) TO BUILD THE FUTURE

6

BIOMANUFACTURING: QUEBEC’S #1 PRIORITY IN LIFE SCIENCES STRATEGY

FAST TRACK

YOUR EXPANSION

IN CHOOSING QUEBEC

INVESTMENT PROSPECTING UNIT

Inspired by the high level of collaboration in Quebec’s Life Sciences ecosystem,

we have optimized investment prospecting efforts with:

8

GOVERNMENT OF QUEBECGREATER MONTREAL

REGIONQUEBEC CITY REGION

BIOTECH

INDUSTRIES

A strong market in Canada with large needs in biomanufacturing

1,450PATENTS FILED

SINCE 2013

CANADA’S BIOTECH PRODUCTS PIPELINE IS GROWING FAST

Source: NRC, 201610

71INSTITUTIONS

196 BIOLOGICS

BETTING ON THE FUTURE

OF CELL THERAPY

An established Canadian Expertise

EXPERTISE AND SERVICES

15

Michael Smith

Laboratories

CellCAN cell and tissue manufacturing facilities offer:

• Clinical trials

• Regulatory filing submissions

• Knowledge mobilisation

• Educational and training support

• Stem cell and tissue production (research, clinical grade)

• Prospective/retrospective ethical, legal and regulatory

screening and compliance

• Ethical, legal and regulatory support

Alberta Cell Therapy

Manufacturing (ACTM)

Philip.S Orsino Facility

For Cell Manufacturing

Centre Multidisciplinaire de

Développement du Génie Tissulaire

Centre of Excellence In Cell Therapy

(CETC)

Ottawa Hospital Research Institute

Center of Genomics

and Policy

QUEBEC’S LIFE SCIENCES

ECOSYSTEM

A major & talented hub on the East Coast

BIOTECHNOLOGY UNIVERSITY PROGRAMS

1: Science, Technology, Engineering, Mathematics

Source: ministère de l’Éducation et de l’Enseignement supérieur (2017)

18

5,000 GRADUATES

30,000 GRADUATES

students graduated from life sciences-related programs

In 2016, in STEM1 fields

in more than 80 quality university programs directly related

to biomanufacturing.

10,000 UNIVERSITY

BILINGUAL AND MULTILINGUAL POPULATION

THE QUEBEC POPULATION IS FLUENT BOTH IN ENGLISH AND FRENCH

Source: Statistics Canada (2016)19

MORE THAN

100

60INTERNATIONAL

ORGANIZATIONS

70ETHNO-CULTURAL

COMMUNITIES

32,000INTERNATIONAL

STUDENTS

OTHER LANGUAGESare spoken in Québec,

including Italian, Spanish,

Arabic, Greek, Mandarin,

German and Portuguese.

“We had a lot of due diligence to select which place

could have been the best in the world. From the

beginning, the Quebec organizations were very

supportive.“

- Green Cross Biotherapeutics Inc.

RECENT INVESTMENT IN BIOMANUFACTURING - MONTREAL

20

2017 GREEN CROSS BIOTHERAPEUTICS

Largest Investment in the Canadian biotech Sector in over a decade

$400 M CAD

RECENT INVESTMENT IN BIOMANUFACTURING – QUEBEC CITY

21

2017 MEDICAGO

$331 M CAD

“We're pleased that Medicago will take this next major

step in Québec City, where we have already

developed our innovative technology”.

- Andy Sheldon, Head of Medicago new ventures

GOVERNMENTAL

SUPPORT

AND INCENTIVES

VARIOUS INCENTIVES TAILORED TO YOUR PROJECT

PROVINCIAL LEVEL23

Strategic Innovation Fund ESSOR Fund for Major Projects

Tax credits for Large Investment Project (c2i)

Tax credit on SR&ED

Financial Assistance for Job Creation and Training

Tax holiday for foreign experts and researchers

QUÉBECCANADA

Canada Economic Development

Tax credit on SR&ED

FEDERAL LEVEL PROVINCIAL LEVEL

ADVANTAGEOUS

COSTS FOR BUSINESS

1stMOST COMPETITIVEoperating costs

RANKED

20 LARGEST

in Canada and

the U.S.

METRO AREAS

Clinical trials

and

Life Science

R&D Centre1

2nd Bio-pharma

manufacturing2

Source: fDi Benchmark, 20181: Research, discovery, design, development or testing of biotechnology or pharmaceutical related products and/or medical devices2: Companies in this industry develop and manufacture therapeutic products and vitro diagnostics using biotechnology

CONTACT

INFORMATION

EXPLORATORY

PHASE

PROJECT

DEFINITIONIMPLEMENTATION GROWTH1 2 3 4

WE CAN ASSIST YOU THROUGH THE WHOLE PROCESSWE CAN ASSIST YOU THROUGH THE WHOLE PROCESS

27

Navigate through

the Life Sciences and

Health Tech ecosystem

Organize a tailored

visit in Quebec

Outline the strategic

options of the project

Assist you to

structure your

project

Assist you with

international mobility

(work permit) and

talent acquisition

Public announcement

Recruit qualified

workers

Support trade and

foreign market

development

Develop key clusters

Foster innovation

Introduce you to key

partners and experts

Identify available

sources of financing

and tax breaks

CHRISTELLE FASANO, PHARM D

Director, Business Development, Life Sciences &

Health Tech – Foreign investments

Montréal International

t +1 514 987-9312

c +1 438 392-4540

christelle.fasano@mtlintl.com

MONTRÉAL INTERNATIONAL

380 Saint-Antoine Street West

Suite 8000

Montréal, Québec H2Y 3X7

t +1 514-987-8191

f +1 514-987-1948

www.montrealinternational.com